Lv62
2580 积分 2024-08-09 加入
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
9天前
已完结
Real-world implementation of a standardized administration protocol for zolbetuximab-associated nausea and vomiting: a retrospective supportive-care cohort study
9天前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
9天前
已完结
Small-cell lung cancer
23天前
已完结
Pain and health-related quality-of-life outcomes with darolutamide in metastatic hormone-sensitive prostate cancer (ARANOTE): secondary and exploratory analyses of a multicentre, randomised, placebo-controlled, phase 3 trial
4个月前
已完结
Use of concomitant G-CSF in maintaining efficacious dose and safe delivery of docetaxel in combination with darolutamide in ARASENS: A phase III study
4个月前
已关闭
Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial
6个月前
已完结
A0851 Treatment outcomes of enfortumab vedotin plus pembrolizumab in lymph node–positive urothelial carcinoma patients fit for cystectomy: Real-world data from an enfortumab registry
6个月前
已完结
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
8个月前
已完结
Higher blood–brain barrier penetration of [14C]apalutamide and [14C]enzalutamide compared to [14C]darolutamide in rats using whole-body autoradiography
8个月前
已关闭
皖公网安备34019202002308
